Bill Details
HR.1947 - 119th Congress
Status
Latest action
2025-03-27 - Referred to the Subcommittee on Health.
Introduced Date
2025-03-06
Policy Area
Armed Forces and National Security
Committees
View committees (2)
Cosponsors
View cosponsors (13)
- Rep. Ogles, Andrew [R-Tennessee-5]
- Rep. Gosar, Paul A. [R-Arizona-9]
- Rep. Nehls, Troy E. [R-Texas-22]
- Rep. Crenshaw, Dan [R-Texas-2]
- Rep. McCormick, Richard [R-Georgia-7]
- Rep. Fitzpatrick, Brian K. [R-Pennsylvania-1]
- Rep. Valadao, David G. [R-California-22]
- Rep. Houlahan, Chrissy [D-Pennsylvania-6]
- Rep. Dean, Madeleine [D-Pennsylvania-4]
- Rep. Murphy, Gregory F. [R-North Carolina-3]
- Rep. Bilirakis, Gus M. [R-Florida-12]
- Rep. Van Drew, Jefferson [R-New Jersey-2]
- Rep. Meuser, Daniel [R-Pennsylvania-9]
6
0
0
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill would require the Department of Veterans Affairs and the Department of Defense to make a treatment called a stellate ganglion block available to eligible veterans and service members who have post-traumatic stress disorder. The treatment would be offered only to people who are enrolled in VA care or TRICARE, have been diagnosed with PTSD, and choose to get the treatment after being told about its risks and benefits by a qualified health care provider. The bill also tells VA and Defense officials to update their PTSD treatment guidelines so they include this therapy and explain when it may help and when it should not be used.
- The treatment would be available to enrolled veterans and active or former service members covered by TRICARE who have PTSD.
- Before getting the treatment, a person must be informed about the possible benefits and risks and must choose to receive it.
- VA and the Defense Department could provide the treatment at their own medical facilities or through approved outside health care providers.
- The two departments must update their joint PTSD clinical guidance within 180 days to include this option and provide Congress with notice of the update.
Official Summaries
No summaries available
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1947 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1947
To direct the Secretary of Veterans Affairs and the Secretary of
Defense to furnish stellate ganglion block to veterans and members of
the Armed Forces with post-traumatic stress disorder, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 6, 2025
Mr. Perry (for himself, Mr. Ogles, Mr. Gosar, Mr. Nehls, Mr. Crenshaw,
Mr. McCormick, Mr. Fitzpatrick, and Mr. Valadao) introduced the
following bill; which was referred to the Committee on Armed Services,
and in addition to the Committee on Veterans' Affairs, for a period to
be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To direct the Secretary of Veterans Affairs and the Secretary of
Defense to furnish stellate ganglion block to veterans and members of
the Armed Forces with post-traumatic stress disorder, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Treatment and Relief through
Emerging and Accessible Therapy for PTSD Act'' or the ``TREAT PTSD
Act''.
SEC. 2. PROVISION OF STELLATE GANGLION BLOCK TO VETERANS AND MEMBERS OF
THE ARMED FORCES WITH POST-TRAUMATIC STRESS DISORDER.
(a) Provision to Veterans.--
(1) In general.--Subchapter II of chapter 17 of title 38,
United States Code, is amended by adding at the end the
following new section:
``Sec. 1720M. Provision of stellate ganglion block for certain veterans
``(a) In General.--The Secretary shall furnish stellate ganglion
block to any veteran who--
``(1) is enrolled in the patient enrollment system under
section 1705 of this title;
``(2) has been diagnosed with post-traumatic stress
disorder; and
``(3) has elected to receive stellate ganglion block after
being informed by a qualified health care provider of the risks
and benefits of stellate ganglion block.
``(b) Provision of Care.--The Secretary may furnish stellate
ganglion block under subsection (a) through a medical facility of the
Department or through a health care provider specified in section
1703(c) of this title.''.
(2) Clerical amendment.--The table of contents at the
beginning of chapter 17 of title 38, United States Code, is
amended by inserting after the item relating to section 1720L
the following new item:
``1720M. Provision of stellate ganglion block for certain veterans.''.
(b) Provision to Members of the Armed Forces.--
(1) In general.--Chapter 55 of title 10, United States
Code, is amended by inserting after section 1074o the following
new section:
``Sec. 1074p. Provision of stellate ganglion block for certain members
``(a) In General.--The Secretary shall furnish stellate ganglion
block to any member of the Armed Forces (including the reserve
components) who is performing or has performed active service and who--
``(1) is enrolled in the TRICARE program under chapter 55
of this title;
``(2) has been diagnosed with post-traumatic stress
disorder; and
``(3) has elected to receive stellate ganglion block after
being informed by a qualified health care provider of the risks
and benefits of stellate ganglion block.
``(b) Provision of Care.--The Secretary may furnish stellate
ganglion block under subsection (a) through a medical facility of the
Department or through a qualified health care provider participating in
a Department administered TRICARE health insurance program.''.
(2) Clerical amendment.--The table of contents at the
beginning of chapter 55 of title 10, United States Code, is
amended by inserting after the item relating to section 1074o
the following new item:
``1074p. Provision of stellate ganglion block for certain members.''.
(c) Update of Joint Clinical Practice Guideline.--
(1) Update of guideline.--Not later than 180 days after the
date of the enactment of this Act, the Secretary of Veterans
Affairs and the Secretary of Defense shall update the guideline
published jointly by the Secretaries and titled the ``VA/DOD
Clinical Practice Guideline (CPG) for the Management of PTSD''
(or such successor guideline) to ensure the guideline--
(A) reflects the availability of stellate ganglion
block as a therapy option; and
(B) includes information on the clinical indicators
and contraindicators for such therapy option.
(2) Notification.--Upon updating the guideline under
paragraph (1), the Secretaries shall notify the appropriate
congressional committees of such update.
(3) Appropriate congressional committees defined.--In this
subsection, the term ``appropriate congressional committees''
means--
(A) the congressional defense committees (as such
term is defined in section 101 of title 10, United
States Code); and
(B) the Committees on Veterans' Affairs of the
House of Representatives and the Senate.
(d) Effective Date.--The amendments made by subsections (a) and (b)
shall take effect on the date that is 180 days after the date of the
enactment of this Act.
<all>